News – Page 89 – Endpoints News

CDC advisors decline to recommend RSV shots to younger at-risk adults, affirming prior guidance

7 months ago

BridgeBio shares promising results in trial of Canavan disease gene therapy

7 months ago

Icon's quarterly earnings hit by biotech and pharma pullback

7 months ago

Lonza extends contract with unnamed pharma; Rentschler's new build

7 months ago

Roche returns to Dyno for its AAV tech with $50M upfront

7 months ago

Marinus plans another round of layoffs, cost cuts following Phase 3 fail

7 months ago

Zai Lab unveils early lung cancer data as it looks to challenge Amgen's Imdelltra

7 months ago

Bayer, Dewpoint to work on heart drug; Viking’s obesity manufacturing plans

7 months ago

Facing lost rebates, MGM Resorts to stop covering GLP-1 weight loss shots

7 months ago

CRISPR therapy reduces swelling attacks by 81% in Intellia follow-up study

7 months ago

Exclusive: University of Toronto spinout raises $53.5M to create new obesity drugs with AI

7 months ago

Novo Nordisk petitions FDA to stop semaglutide compounding over safety risks

7 months ago

GSK offers glimpse at RSV vaccine in at-risk younger adults before ACIP meeting

7 months ago

Exclusive: Moldova clears first gene editing study for HBV in humans

7 months ago

Adults 50 and up should get pneumococcal vaccine, CDC advisors say, in boost to Pfizer and Merck

7 months ago

Pfizer wins approval to expand RSV vaccine to adults at higher infection risk

7 months ago

Novo Nordisk asks FDA to prohibit semaglutide compounding, following Eli Lilly

7 months ago

Allowing Novo-Catalent deal to close would be ‘wrong decision’ by antitrust authorities, Roche CEO says

7 months ago

Thermo Fisher predicts revenue uptick in 2025 as it expects headwinds to ease

7 months ago

Eccogene gets $60M from AstraZeneca; Evotec also records milestone with BMS

7 months ago

Alto Neuroscience's mid-stage trial misses primary endpoint in depression

7 months ago

Radiopharma startups stay hot as Alpha-9 bags $175M Series C

7 months ago

Life sciences investor Dimension seeks to raise $500M second fund

7 months ago

Houston startup March Biosciences raises $28M to get CAR-T into Phase 2

7 months ago

First page Previous page 86 87 888990 91 92 Next page Last page